XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Business Segments (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Significant components of the Company's continuing operations and selected balance sheet items
Three months ended March 31, 2022
Specialty

Commercial
International
Life &
Group (1)
Corporate
& Other
  
(In millions)Eliminations
Total (1)
Operating revenues 
Net earned premiums$772 $904 $264 $120 $(1)$— $2,059 
Net investment income103 118 14 212 — 448 
Non-insurance warranty revenue382 — — — — — 382 
Other revenues(1)(1)(2)
Total operating revenues1,258 1,030 277 331 (2)2,896 
Claims, benefits and expenses    
Net incurred claims and benefits 445 573 158 304 (8)— 1,472 
Policyholders’ dividends— — — — 
Amortization of deferred acquisition costs157 148 39 — — — 344 
Non-insurance warranty expense354 — — — — — 354 
Other insurance related expenses81 130 47 31 — 291 
Other expenses13 41 (2)63 
Total claims, benefits and expenses1,051 863 245 338 35 (2)2,530 
Core income (loss) before income tax207 167 32 (7)(33)— 366 
Income tax (expense) benefit on core income (loss)(44)(35)(6)12 — (68)
Core income (loss)$163 $132 $26 $$(28)$— 298 
Net investment gains (losses)(11)
Income tax (expense) benefit on net investment gains (losses)
Net investment gains (losses), after tax(3)
Net income (loss)$295 
December 31, 2022
(In millions)
Reinsurance receivables$1,384 $1,062 $414 $101 $2,477 $— $5,438 
Insurance receivables1,082 1,728 369 — — 3,187 
Deferred acquisition costs381 321 104 — — — 806 
Goodwill117 — 27 — — — 144 
Deferred non-insurance warranty acquisition expense3,671 — — — — — 3,671 
Insurance reserves 
Claim and claim adjustment expenses6,878 9,395 2,403 695 2,749 — 22,120 
Unearned premiums3,193 2,425 653 103 — — 6,374 
Future policy benefits— — — 13,480 — — 13,480 
Deferred non-insurance warranty revenue4,714 — — — — — 4,714 
(1) As of January 1, 2023, the Company adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been adjusted to reflect application of the new guidance. See Note A to the Condensed Consolidated Financial Statements for additional information.
Revenues by line of business
The following table presents operating revenues by line of business for each reportable segment.
Three months ended March 31
(In millions)20232022
Specialty
Management & Professional Liability$705 $673 
Surety168 148 
Warranty & Alternative Risks460 437 
Specialty revenues1,333 1,258 
Commercial
Middle Market398 362 
Construction385 324 
Small Business150 138 
Other Commercial269 206 
Commercial revenues1,202 1,030 
International
Canada93 88 
Europe127 120 
Hardy93 69 
International revenues313 277 
Life & Group revenues329 331 
Corporate & Other revenues 13 
Eliminations(3)(2)
Total operating revenues3,187 2,896 
Net investment gains (losses)(35)(11)
Total revenues$3,152 $2,885